Shares in vaccine developers jumped on Tuesday after the US reported its first human death from the H5 strain of bird flu.
Moderna’s stock rose 11.6 per cent, Novavax gained 10.8 per cent and CureVac’s shares advanced 5 per cent. Shares in Pfizer, one of the biggest US drugmakers, added nearly 1 per cent.
The US Centers for Disease Control and Prevention on Monday confirmed the death of an elderly patient with underlying medical conditions from the H5 strain of bird flu in Louisiana.
您已阅读19%（486字），剩余81%（2069字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。